GlassScriptPhysician profile
Barrett Martin
NPI 1366878878
$2,022.77
in general payments reported to CMS, 2019-2025
14 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $64.05 · 2021: $163 · 2022: $335 · 2023: $580 · 2024: $374 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $665.75 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Alcon Vision LLC | $434.62 | 2019-2025 | Hydrus Microstent, Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $321.65 | 2021-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $211.46 | 2019-2021 | |
| Coopervision INC. | $70.12 | 2019-2021 | |
| Optos, INC. | $64.77 | 2019 | |
| Abbvie INC. | $57.36 | 2023 | |
| Horizon Therapeutics Plc | $46.53 | 2023 | Tepezza |
| Amgen INC. | $40.27 | 2024 | Tepezza |
| Biotissue Holdings INC. | $30.00 | 2020-2023 | |
| Oyster Point Pharma, INC. | $28.32 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $19.06 | 2022 | |
| Thea Pharma INC. | $18.21 | 2023 | |
| Abb Con-Cise Optical Group LLC | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barrett Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.